European Institute Of Oncology

This study is testing whether combining two hormone-based drugs, elacestrant and exemestane, can help control advanced breast cancer that has worsened after initial treatment. It will enroll 26 patients whose cancer is still driven by hormones, as confirmed by a special PET scan.…

This study aims to understand how well a blood test can detect tiny amounts of leftover cancer DNA after surgery. It will follow 840 patients with breast, lung, prostate, ovarian, or gastric cancer to see if this 'liquid biopsy' can predict if the cancer might come back. The stud…

This study aims to understand why some endometrial cancer patients respond better to immunotherapy than others. Researchers will analyze tumor tissue from 50 patients with advanced or recurrent cancer to look for biological markers that predict treatment success. The goal is to h…

This study aims to understand how often people with endometrial cancer have inherited changes in specific genes. Researchers will analyze blood samples from 20 participants who already have a specific tumor gene change. The goal is to gather knowledge that could help guide future…